BRCA1 and breast carcinoma: The PRS for ER-negative breast cancer displayed the strongest association with breast cancer risk in BRCA1 carriers (per standard deviation HR = 1.27, 95% confidence interval [CI] = 1.23 to 1.31, P = 8.2×10−53) (Table 1).